Cite

HARVARD Citation

    Tan, T. et al. (2021). Safety and efficacy of an extended‐release peptide YY analogue for obesity: A randomized, placebo‐controlled, phase 1 trial. Diabetes, obesity & metabolism. 23 (7), pp. 1471-1483. [Online]. 
  
Back to record